SON Clinical Trials

1,148 recruitingLast updated: July 25, 2026

There are 1,148 actively recruiting son clinical trials across 61 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Boston, Massachusetts, United States, Beijing, Beijing Municipality, China, New York, New York, United States. Updated daily from ClinicalTrials.gov.


SON Trials at a Glance

1,148 actively recruiting trials for son are listed on ClinicalTrialsFinder across 6 cities in 61 countries. The largest study group is Not Applicable with 543 trials, with the heaviest enrollment activity in Boston, Beijing, and New York. Lead sponsors running son studies include University of Minnesota, VA Office of Research and Development, and National Taiwan University Hospital.

Treatments under study

About SON Clinical Trials

Looking for clinical trials for SON? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new SON trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about SON clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,148 trials

Recruiting
Phase 1Phase 2

Personalized Neoantigen Peptide Vaccines for Solid Tumors

Solid TumorsAdvanced CancerRecurrent Cancer+2 more
Seqker Biosciences, Inc.10 enrolled1 locationNCT07002203
Recruiting

Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA Gene

Idiopathic Parkinson's Disease (PD)
Azienda USL Reggio Emilia - IRCCS3,000 enrolled4 locationsNCT06814431
Recruiting

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

SYNGAP1-Related Intellectual DisabilityDLG4FOXP1+184 more
Simons Searchlight100,000 enrolled2 locationsNCT01238250
Recruiting
Phase 1

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

Early-stage Parkinson’s diseaseParkinson's Disease (PD)Mild to Moderate Parkinson's Disease
Mission Therapeutics106 enrolled18 locationsNCT07630545
Recruiting

"Turkish Validity and Reliability of the Heat Sensitivity Scale for Individuals With Parkinson's Disease"

Parkinson DiseaseTemperature Sensivity
Acibadem University100 enrolled1 locationNCT07710625
Recruiting

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

Mesonephric-like Adenocarcinoma
M.D. Anderson Cancer Center2,000 enrolled1 locationNCT06377527
Recruiting
Phase 2

Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

Parkinson Disease
Gateway Institute for Brain Research56 enrolled4 locationsNCT05266417
Recruiting
Phase 2

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

Mesonephric Gynecologic Cancer
Memorial Sloan Kettering Cancer Center40 enrolled7 locationsNCT05787561
Recruiting
Not Applicable

The Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson Disease

Parkinson Disease, Idiopathic
University of Florida100 enrolled1 locationNCT07026734
Recruiting
Not Applicable

Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease

Parkinson's Disease
University of Nebraska10 enrolled1 locationNCT04799470
Recruiting
Phase 2Phase 3

A Study of Buntanetap in Participants With PD

Deep Brain StimulationParkinson's Disease (PD)
Annovis Bio Inc.500 enrolled27 locationsNCT07284784
Recruiting
Phase 2Phase 3

Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of VG081821AC Tablets in Patients With Early to Mid-stage Parkinson's Disease

Parkinson Disease (PD)
Zhejiang Vimgreen Pharmaceuticals, Ltd.152 enrolled1 locationNCT07725562
Recruiting
Not Applicable

Motor Network Physiology

Parkinson DiseaseEssential Tremor
University of Texas Southwestern Medical Center120 enrolled1 locationNCT04957095
Recruiting
Phase 2

Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease

StrokeParkinson DiseaseDysphagia
Purdue University120 enrolled2 locationsNCT06638944
Recruiting
Not Applicable

Different Frequency Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease

Parkinson Disease (PD)
Ke Dong, MD60 enrolled1 locationNCT07721688
Recruiting

Artificial Intelligence-Assisted Advanced Analysis of Knee Imaging and Outcome Prediction

Artificial IntelligenceKnee OsteoarthritisDegenerative Knee Disorders+1 more
National Taiwan University Hospital310 enrolled1 locationNCT07721116
Recruiting
Not Applicable

Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome

Parkinson DiseaseParkinson Disease, Secondary
Ke Dong, MD60 enrolled1 locationNCT07568067
Recruiting
Phase 1

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Influenza PreventionSeasonal Influenza
National Institute of Allergy and Infectious Diseases (NIAID)45 enrolled1 locationNCT06863142
Recruiting
Not Applicable

The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease

Parkinson's Disease
The First Affiliated Hospital of Anhui Medical University90 enrolled1 locationNCT07572903
Recruiting

Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)

Multiple SclerosisAlzheimer DiseaseParkinson Disease+2 more
IRCCS San Raffaele1,050 enrolled1 locationNCT07720765